Letter | Published:

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

Nature volume 475, pages 9195 (07 July 2011) | Download Citation

Abstract

Clinical studies consistently demonstrate that a single sub-psychomimetic dose of ketamine, an ionotropic glutamatergic NMDAR (N-methyl-D-aspartate receptor) antagonist, produces fast-acting antidepressant responses in patients suffering from major depressive disorder, although the underlying mechanism is unclear1,2,3. Depressed patients report the alleviation of major depressive disorder symptoms within two hours of a single, low-dose intravenous infusion of ketamine, with effects lasting up to two weeks1,2,3, unlike traditional antidepressants (serotonin re-uptake inhibitors), which take weeks to reach efficacy. This delay is a major drawback to current therapies for major depressive disorder and faster-acting antidepressants are needed, particularly for suicide-risk patients3. The ability of ketamine to produce rapidly acting, long-lasting antidepressant responses in depressed patients provides a unique opportunity to investigate underlying cellular mechanisms. Here we show that ketamine and other NMDAR antagonists produce fast-acting behavioural antidepressant-like effects in mouse models, and that these effects depend on the rapid synthesis of brain-derived neurotrophic factor. We find that the ketamine-mediated blockade of NMDAR at rest deactivates eukaryotic elongation factor 2 (eEF2) kinase (also called CaMKIII), resulting in reduced eEF2 phosphorylation and de-suppression of translation of brain-derived neurotrophic factor. Furthermore, we find that inhibitors of eEF2 kinase induce fast-acting behavioural antidepressant-like effects. Our findings indicate that the regulation of protein synthesis by spontaneous neurotransmission may serve as a viable therapeutic target for the development of fast-acting antidepressants.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 63, 856–864 (2006)

  2. 2.

    et al. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47, 351–354 (2000)

  3. 3.

    , , & Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol. Psychiatry 66, 522–526 (2009)

  4. 4.

    et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol. Psychiatry 63, 349–352 (2008)

  5. 5.

    , & Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp. Clin. Psychopharmacol. 5, 107–112 (1997)

  6. 6.

    & Ketamine. Handb. Exp. Pharmacol. 182, 313–333 (2008)

  7. 7.

    & Cardiac arrest and resuscitation alters the pharmacokinetics of MK-801 in the rat. Res. Commun. Chem. Pathol. Pharmacol. 73, 181–195 (1991)

  8. 8.

    , , , & CSF and plasma pharmacokinetics of the NMDA receptor antagonist CPP after intrathecal, extradural and i.v. administration in anaesthetized pigs. Br. J. Anaesth. 74, 193–200 (1995)

  9. 9.

    , , , & Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 50, 260–265 (2001)

  10. 10.

    et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc. Natl Acad. Sci. USA 101, 10827–10832 (2004)

  11. 11.

    et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311, 864–868 (2006)

  12. 12.

    , , , & Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol. Psychiatry 63, 642–649 (2008)

  13. 13.

    , , , & Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22, 3251–3261 (2002)

  14. 14.

    , & Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res. 1037, 204–208 (2005)

  15. 15.

    et al. Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons. J. Neurosci. 22, 4153–4162 (2002)

  16. 16.

    & Different requirements for protein synthesis in acquisition and extinction of spatial preferences and context-evoked fear. J. Neurosci. 21, 5773–5780 (2001)

  17. 17.

    , , , & Actinomycin D blocks the reducing effect of dexamethasone on amphetamine and cocaine hypermotility in mice. Gen. Pharmacol. 27, 707–712 (1996)

  18. 18.

    , , , & Postsynaptic decoding of neural activity: eEF2 as a biochemical sensor coupling miniature synaptic transmission to local protein synthesis. Neuron 55, 648–661 (2007)

  19. 19.

    et al. NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice. Pharmacol. Biochem. Behav. 88, 158–164 (2007)

  20. 20.

    et al. Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nature Neurosci. 10, 411–413 (2007)

  21. 21.

    et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959–964 (2010)

  22. 22.

    et al. Antidepressive-like effects of rapamycin in animal models: Implications for mTOR inhibition as a new target for treatment of affective disorders. Brain Res. Bull. 76, 469–473 (2008)

  23. 23.

    et al. Spontaneous and evoked glutamate release activates two populations of NMDA receptors with limited overlap. J. Neurosci. 28, 10151–10166 (2008)

  24. 24.

    & NMDA receptor activation by spontaneous glutamatergic neurotransmission. J. Neurophysiol. 101, 2290–2296 (2009)

  25. 25.

    et al. Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines. Science 319, 1683–1687 (2008)

  26. 26.

    et al. Local presynaptic activity gates homeostatic changes in presynaptic function driven by dendritic BDNF synthesis. Neuron 68, 1143–1158 (2010)

  27. 27.

    et al. Postsynaptic GluA1 enables acute retrograde enhancement of presynaptic function to coordinate adaptation to synaptic inactivity. Proc. Natl Acad. Sci. USA 107, 21806–21811 (2010)

  28. 28.

    & Partitioning the synaptic landscape: distinct microdomains for spontaneous and spike-triggered neurotransmission. Sci. Signal. 2, pe19 (2009)

  29. 29.

    et al. Spontaneous neurotransmission: an independent pathway for neuronal signaling? Physiology (Bethesda) 26, 45–53 (2011)

  30. 30.

    , , , & A role for MAP kinase signalling in behavioral models of depression and antidepressant treatment. Biol. Psychiatry 61, 661–670 (2007)

  31. 31.

    , & Depression: A new animal model sensitive to antidepressant treatments. Nature 266, 730–732 (1977)

  32. 32.

    et al. Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD. Neuron 59, 70–83 (2008)

  33. 33.

    , & Activity-dependent regulation of synaptic clustering in a hippocampal culture system. Proc. Natl Acad. Sci. USA 96, 12893–12900 (1999)

Download references

Acknowledgements

We thank M. A. Mahgoub for assistance with the animal experiments, S. Birnbaum and A. Pettersen for assistance with the behavioural testing and members of the Monteggia and Kavalali laboratories for discussions and comments on the manuscript. This work was supported by grant MH070727 (L.M.M.), grant MH066198 (E.T.K.) and the Division of Basic Sciences Training Program at UT Southwestern Medical Center, T32 MH 76690-02 (A.E.A.). E.T.K. is an Established Investigator of the American Heart Association.

Author information

Affiliations

  1. Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9111, USA

    • Anita E. Autry
    • , Megumi Adachi
    • , Elisa S. Na
    • , Maarten F. Los
    • , Peng-fei Cheng
    •  & Lisa M. Monteggia
  2. Department of Neuroscience, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9111, USA

    • Elena Nosyreva
    •  & Ege T. Kavalali

Authors

  1. Search for Anita E. Autry in:

  2. Search for Megumi Adachi in:

  3. Search for Elena Nosyreva in:

  4. Search for Elisa S. Na in:

  5. Search for Maarten F. Los in:

  6. Search for Peng-fei Cheng in:

  7. Search for Ege T. Kavalali in:

  8. Search for Lisa M. Monteggia in:

Contributions

A.E.A. performed the behavioural experiments. A.E.A., M.A. and M.F.L. contributed to the molecular experiments. E.N. performed the electrophysiology experiments, E.S.N. performed the TrkB behavioural experiments and A.E.A. and P.-f.C. performed the statistical analyses. A.E.A. also made the figures and wrote the corresponding sections of the paper. E.T.K. and L.M.M. designed the study, supervised the experiments and wrote the paper.

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Ege T. Kavalali or Lisa M. Monteggia.

Supplementary information

PDF files

  1. 1.

    Supplementary Figures

    The file contains Supplementary Figures 1-15 with legends.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nature10130

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.